Abstract
Due to the development in the last decade of rapid and sensitive bacterial genetic test systems for detecting potential mutagens and carcinogens(1–3) there has been a recrudescence of testing of environmental chemicals for genotoxicity. Experiments performed in particular with theSalmonella/mammalian microsome test,(4,5) in which the ability of chemicals to cause reversion in auxotrophicSalmonella strains is determined on selective agar medium under the influence of various mammalian organ fractions, have yielded results on a variety of environmental compounds that show definite mutagenic activity in this assay system and are therefore to be considered as potentially mutagenic and carcinogenic in animals (see also Refs. 6 and 7).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B. J. Kilbey, M. Legator, W. Nichols, and C. Ramel, (eds.),Handbook of Mutagenicity Test Procedures, Elsevier, Amsterdam (1984).
K. H. Norpoth, and R. C. Garner, (eds.),Short-Term Test Systems for Detecting Carcinogens, Springer, Berlin (1980).
F. J. de Serres and J. Ashby, (eds.),Evaluation of Short-Term Tests for Carcinogens, Elsevier/North-Holland, Amsterdam (1981).
B. N. Ames, J. McCann, and E. Yamasaki, Methods for detecting carcinogens and mutagens with theSalmonella/mammalian microsome mutagenicity test,Mutat. Res. 31, 347–364 (1975).
D. M. Maron and B. N. Ames, Revised methods for theSalmonella mutagenicity test,Mutat. Res. 113, 173–215 (1983).
ICPEMC, International Commission for Protection against Environmental Mutagens and Carcinogens, Committee 1 Final Report,Mutat. Res. 114, 117–177 (1983).
ICPEMC,International Commission for Protection against Environmental Mutagens and Carcinogens, Committee 2 Final Report, Elsevier Biomedical Press, Amsterdam (1982).
J. McCann, E. Choi, E. Yamasaki, and B. N. Ames, Detection of carcinogens as mutagens in theSalmonella/microsome test: Assay of 300 chemicals, Proc. Natl. Acad. Sei. USA 12, 4135–5139 (1975).
F. J. de Serres and M. D. Shelby, (eds.),Comparative Chemical Mutagenesis, Springer Science+Business Media New York (1981).
IARC,International Agency for Research on Cancer Monographs, Long-Term and Short-Term Screening Assays for Carcinogenesis: A Critical Appraisal, I ARC, Lyon (1980).
J. McCann and B. N. Ames, TheSalmonella/microsome mutagenicity test: Predictive value for animal carcinogenicity, in:Origins of Human Cancer (H. H. Hiattet al, eds.), Book C, pp. 1431–1450, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1977).
M. Meselson and K. Russell, Comparisons of carcinogenic and mutagenic potency, in:Origins of Human Cancer (H. H Hiattet al., eds.), Book C, pp. 1473–1481, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1977).
B. N. Ames and K. Hooper, Does carcinogenic potency correlate with mutagenic potency in the Ames assay?Nature 214, 19–20 (1978).
J. Ashby and J. A. Styles, Factors affecting mutagenic potency in vitro,Nature 214, 20–22 (1978).
J. Ashby, Implications of carcinogenicity, in:Mutagenesis in Sub-mammalian Systems. Status and Significance (F. E. Paget, ed.), pp. 165–184, MIT Press, Cambridge, Massachusetts (1979).
G. R. Mohn, Bacterial systems for carcinogenicity testing,Mutat. Res. 87, 191–210 (1981).
G. R. Mohn, On the correlation between mutagenicity and carcinogenicity, in:Genetic Origins of Tumor Cells (F. J. Cleton and J. W. I. M. Simons, eds.), pp. 11–24, Martinus Nijhoff, The Hague (1980).
E. P. Reddy, R. K. Reynolds, E. Santos, and M. Barbacid, A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene,Nature 300, 149–152 (1982).
G. Mardon and H. E. Varmus, Frameshift and intragenic suppressor mutations in a Rous sarcoma provirus suggestsrc encodes two proteins,Cell 32, 871–879 (1983).
E. Taparowsky, Y. Suard, O. Fasano, K. Shimizu, M. Goldfarb, and M. Wigler, Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change,Nature 300, 762–765 (1982).
G. R. Mohn, A. A. van Zeeland, and B. W. Glickman, Influence of experimental conditions and DNA repair ability on EMS-induced mutagenesis and DNA binding inEscherichia coli K-12. Comparison with mammalian cell mutagenesis,Mutat. Res. 92, 15–27 (1982).
C. S. Aaron, A. A. van Zeeland, G. R. Mohn, A. T. Natarajan, A. G. A. C. Knaap, A. D. Tates, and B. W. Glickman, Molecular dosimetry of the chemical mutagen ethyl methanesulfonate. Quantitative comparison of mutation induction inEscherichia coli, V79 Chinese hamster cells and L5178Y mouse lymphoma cells, and some cytological resultsin vitro andin vivo, Mutat. Res.69, 201–216 (1980).
G. R. Mohn, T.-M. Ong, D. F. Callen, P. G. N. Kramers, and C. S. Aaron, Comparison of the genetic activity of 5-nitroimidazole derivatives inEscherichia coli, Neurospora crassa, Saccharomyces cerevisiae, andDrosophila melanogaster, J. Environ. Pathol. Toxicol.2, 657–670 (1979).
M. G. Gabridge, A. DeNunzio, and M. S. Legator, Microbial mutagenicity of streptozotocin in animal-mediated assays,Nature 221, 68–70 (1969).
G. M. Williams, R. Kroes, H. W. Waaijers, and K. W. van de Poll, eds.,Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation, Elsevier/North-Holland, Amsterdam (1980).
G. Mohn and J, Ellenberger, Mammalian blood-mediated mutagenicity tests using a multipurpose strain ofEscherichia coli K-12,Mutat. Res. 19, 257–260 (1973).
G. Mohn, J. Ellenberger, D. McGregor, and H.-J. Merker, Mutagenicity studies in microorganismsin vitro, with extracts of mammalian organs, and with the host-mediated assay,Mutat. Res. 29, 221–233 (1975).
P. Kerklaan, G. Mohn, and S. Bouter, Comparison of the mutagenic activity of dialkylnitrosamines in animal-mediated andin vitro assays using anEscherichia coli indicator,Carcinogenesis 2, 909–914 (1981).
P. Kerklaan, S. Bouter, and G. Mohn, Mutagenic activity of three isomeric N-nitroso-N-methylamino-pyridines towardsEscherichia coli K-12in vitro and animal-mediated assays,Carcinogenesis 3, 415–421 (1982).
G. R. Mohn and J. Ellenberger, The use ofEscherichia coli K-12/343/113(λ) as a multipurpose indicator strain in various mutagenicity testing procedures, in:Handbook of Mutagenicity Test Procedures (B. Kilbeyet al, eds.), pp. 95–118, Elsevier/North-Holland, Amsterdam (1977).
B. J. Bachmann and K. B. Low, Linkage map ofEscherichia coli K-12, edition 6,Microbiol. Rev. 44, 1–56 (1980).
R. Favre, A. Wiater, S. Puppo, M. Iaccarino, R. Noelle, and M. Freundlich, Expression of a valine-resistant acetolactate synthase activity mediated by theilvO andilvG genes ofEscherichia coli K-12,Mol. Gen. Genet. 143, 243–252 (1976).
M. W. Hane and T. H. Wood,Escherichia coli K-12 mutants resistant to nalidixic acid: Genetic mapping and dominance studies,J. Bacteriol. 99, 238–241 (1969).
P. Howard-Flanders and L. Theriot, Mutants ofEscherichia coli K-12 defective in DNA repair and in genetic recombination,Genetics 53, 1137–1150 (1966).
T. Kato and S. Kondo, Two types of x-ray sensitive mutants ofEscherichia coli B: Their phenotypic characters compared with UV sensitive mutants,Mutat. Res.4, 253– 263 (1967).
A. Rörsch, P. van de Putte, I. E. Mattern, and H. Zwenk, in:Radiation Research. Proceeding of the Third International Congress of Radiation Research ( G. Silini, ed.), pp. 771–789, Elsevier/North-Holland, Amsterdam (1967).
R. P. Boyce and P. Howard-Flanders, Genetic control of DNA breakdown and repair inE. coli K-12 treated with mitomycin C or ultraviolet light,Z. Vererbungsl.95, 345– 350 (1964).
K. W. Kohn, H. H. Steigbigel, and C. L. Spears, Cross-linking and repair of DNA in sensitive and resistant strains ofE. coli treated with nitrogen mustard,Proc. Natl. Acad. Sei. USA 53, 1154–1161 (1965).
P. de Lucia and J. Cairns, Isolation of anE. coli strain with a mutation affecting DNA polymerase,Nature 224, 1164–1166 (1969).
P. E. Hartman, Bacterial mutagenesis: Review of new insights,Environ. Mutagen. 2, 3–16 (1980).
P. C. Hanawalt, P. K. Cooper, A. K. Ganesan, and C. A. Smith, DNA repair in bacteria and mammalian cells,Annu. Rtv. Biochem. 48, 783–836 (1979).
E. E. Slater, M. D. Anderson, and H. S. Rosenkranz, Rapid detection of mutagens and carcinogens,Cancer Res.31, 970–973 (1971).
T. Kada, K. Tutikawa, and J. Sadaie,In vitro and host-mediated“rec-assay” procedures for screening chemical mutagens; and phloxine, a mutagenic red dye detected,Mutat. Res. 16, 165–174 (1972).
M. Nagao and T. Sugimura, Sensitivity of repair-deficient mutants and similar mutants to N-nitroquinoline-l-oxide, N-nitropyridine-l-oxide, and their derivatives,Cancer Res.31, 2369–2374 (1972).
Z. Leifer, T. Kada, M. Mandel, E. Zeiger, R. Stafford, and H. S. Rosenkranz, An evaluation of tests using DNA repair-deficient bacteria for predicting genotoxicity and carcinogenicity, A report of the US EPA’s Gene-Tox program,Mutat. Res. 87, 211–297 (1981).
R. E. W. Hancock and P. Reeves, Lipolysaccharide-deficient bacteriophage-resistant mutants ofEscherichia coli K-12,J. Bacteriol. 127, 98–108 (1980).
B. N. Ames, F. D. Lee, and W. E. Durston, An improved bacterial test system for the detection and classification of mutagens and carcinogens,Proc. Natl. Acad. Sci. USA 70, 782–786.
G. Mohn, P. Kerklaan, P. de Knijff, and S. Bouter, Influence of phenotypic expression lag and division delay on apparent frequencies of induced mutations inEscherichia coli K-12,Mutat. Res. 91, 419–425 (1981).
M. Lipkin and R. Good, eds.,Gastro-Intestinal Tract Cancer and Carcinogenesis, Springer Science+Business Media New York (1978).
L. A. Wheeler, J. H. Carter, F. B. Soderberg, and P. Goldman, Association ofSalmonella mutants with germfree rats: Site specific model to detect carcinogens as mutagens,Proc. Natl. Acad. Sei. USA 72, 4607–4611 (1975).
R. Barale, D. Zucconi, M. Romano, and N. Loprieno, The intragastric host-mediated assay for the assessment of the formation of direct mutagensin vivo, Mutat. Res.113, 21–32 (1983).
E. Baibinder, G. I. Reich, D. Shugarts, J. Keogh, R. Fibiger, T. Jones, and A. Banks, Relative mutagenicity of some urinary metabolites of the anti-tumor drug cyclophosphamide,Cancer Res.41, 2967–2972 (1981).
K. Yano and M. Isobe, Mutagenicity ofN-methyl-N’-aryl-N-nitrosoureas andN- methyl-N’-methyl-N-nitrosoureas in relation to their alkylating activity,Cancer Res.39, 5147–5149 (1979).
K. Hemminki and K. Falck, Correlation of mutagenicity and 4-(p-nitrobenzyl)-pyridine alkylation by epoxides,Toxicol. Lett. 4, 103–106 (1979).
E. Eder, T. Neudecker, D. Lutz, and D. Henschler, Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and directin vitro mutagenic properties,Biochem. Pharmacol. 29, 993–998 (1980).
A. W. Wood, R. L. Chang, W. Levin, D. E. Ryan, P. E. Thomas, R. E. Lehr, S. Kumar, M. Schaefer-Ridder, U. Engelhardt, H. Yagi, D. M. Jerina, and A. H. Conney, Mutagenicity of diolepoxides and tetrahydroepoxides of benz(a)acridine and benz(c)acridine in bacteria and in mammalian cells,Cancer Res.43, 1656–1662 (1983).
R. Majumbar, S. C. Mathur, and K. Roy, Mutagenicity and K-region reactivity of monomethyl derivatives of benz(a)anthracene in a self-consistent-field molecular orbital theory,Biochem. Biophys. Res. Commun. 106, 836–841 (1982).
R. Hauser and B. Matter, Localization ofE. coli K-12 in livers of mice used for an intrasanguineous host-mediated assay,Mutat. Res. 46, 45–48 (1977).
P. Arni, The microbial host-mediated assay in comparison within vitro systems: Problems and evaluation, predictive value, and practical application, in:Short-Term Test Systems for Detecting Carcinogens (K. H. Norpoth and R. C. Garner, eds.), pp. 190– 198, Springer, Berlin (1980).
D. Frezza, B. Smith, and E. Zeiger, The intrasanguineous host-mediated assay procedure usingSaccharomyces cerevisiae: Comparison with two other metabolic activation systems,Mutat. Res. 108, 161–168 (1983).
W.-Z. Whong and T. Ong, Mediated mutagenesis of dimethylnitrosamine inNeurospora crassa by various metabolic activation systems,Cancer Res.39, 1525–1528 (1979).
H. Druckrey, R. Preussmann, S. Ivankovic, and D. Schmähl, Organotrope carcinogene Wirkungen bei 65 verschiedenenN-Nitroso Verbindungen an BD Ratten, Z.Kerbs– forsch.69, 103–201 (1967).
W. Lijinsky, M. D. Reuber, and W. B. Manning, Potent carcinogenicity of nitrosodi-ethanolamine in rats,Nature 288, 289–590 (1980).
G. Reznik, U. Mohr, and F. W. Krüger, Carcinogenic effect of di-n-propyl-nitrosamine, ß-hydroxy-propyl-n-propylnitrosamine, and methyl-n-propyl-nitrosamine on Sprague Dawley rats,J. Natl. Cancer Inst. 54, 937–943 (1975).
G. R. Mohn, P. R. M. Kerklaan, W. P. C. ten Bokkum-Coenradi, and T. E. M. ten Hulscher, A differential DNA repair test using mixtures of strains ofE. coli K-12 in liquid suspension and animal-mediated assays,Mutat. Res. 113, 404–415 (1983).
P. N. Magee and J. M. Barnes, Carcinogenic nitroso compounds,Adv. Cancer Res. 10, 163–246 (1967).
A. E. Pegg and J. W. Nicoll, Nitrosamine carcinogenesis: The importance of the persistence in DNA of alkylated bases in the organotropism of tumor induction, in:Screening Tests in Chemical Carcinogenesis (R. Montesano, H. Bartsch, and L. Tomatis, eds.), pp. 571–590, IARC, Lyon (1976).
IARC,Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17,Some Nitroso Compounds, IARC, Lyon (1978).
IARC,Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 7,Some Anti-thyroid and Related Substances, Nitrofurans and Industrial Chemicals, IARC, Lyon (1974).
B. F. Swann and P. N. Magee, Nitrosamine induced carcinogenesis. The alkylation of nucleic acids of the rat byN-methyl-N-nitrosourea, dimethyl nitrosamine, and methyl methanesulfonate,Biochem.J. 110, 39–47 (1968).
B. F. Swann, The rate of breakdown of methyl methanesulphonate, dimethyl sulfate andN-methyl-N-nitrosourea in the rat,Biochem. J,110, 49–52 (1968).
D. F. Heath, The decomposition and toxicity of dialkylnitrosamines in rats,Biochem. J. 85, 72–91 (1962).
IARC,Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Supplement 4,Chemicals, Industrial Processes and Industries Associated with Cancer in Humans, IARC, Lyon (1982).
J. Ellenberger and G. Mohn, Mutagenic activity of major mammalian metabolites of cyclophosphamide toward several genes ofEscherichia coli, J. Toxicol. Environ. Health 3, 585–599 (1977).
J. J. Wong and D. P. H. Hsieh, Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential,Proc. Natl. Acad. Sci. USA 73, 2241–2244 (1976).
G. R. Mohn, P. R. M. Kerklaan, A. A. van Zeeland, J. Ellenberger, R. A. Baan, P. H. M. Lohman, and F. W. Pons, Methodologies for the determination of various genetic effects in permeable strains ofE. coli K-12 differing in DNA repair capacity. Quantification of DNA adduct formation, experiments with organ homogenates and hepatocytes, and animal-mediated assays,Mutation Res.125, 153–184 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mohn, G.R., Kerklaan, P.R.M., van Elburg, P.A. (1984). The Use of Multiply Marked Escherichia coli K12 Strains in the Host-Mediated Assay. In: de Serres, F.J. (eds) Chemical Mutagens. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2771-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2771-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9711-6
Online ISBN: 978-1-4613-2771-4
eBook Packages: Springer Book Archive